Anlon Healthcare

Anlon Healthcare EBIT Margin

The EBIT Margin (Operating Margin) of Anlon Healthcare (AHCL.NS) as of Nov 16, 2026 is 26.91 %. In the previous year, EBIT Margin (Operating Margin) was 25.41 % — a change of 5.90% (higher).

EBIT Margin

26.91 %

YoY

5.90%

Last updated:

EBIT Margin (Operating Margin) of Anlon Healthcare is 2026 26.91 % . EBIT Margin (Operating Margin) of Anlon Healthcare was 2025 25.41 % . It decreases by 5.90% higher compared to the previous year.

For Anlon Healthcare, the operating (EBIT) margin of 26.9% is up versus 6.3% a few years ago.

The Anlon Healthcare EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2022
6.26 INR
Jan 1, 2023
9.64 INR
Jan 1, 2024
20.79 INR
Jan 1, 2025
25.41 INR
Jan 1, 2026
26.91 INR
The Anlon Healthcare EBIT Margin history
YEAREBIT MarginYoY
26.91 %+5.90%
25.41 %+22.21%
20.79 %+115.64%
9.64 %+54.04%
6.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Anlon Healthcare Stock analysis

What does Anlon Healthcare do? Anlon Healthcare Ltd. generates revenue through the production and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), nutraceutical APIs, and ingredients for personal care and veterinary applications. Its product portfolio includes 3-(1-cyanoethyl) benzoic acid (CEBA), ketoprofen ethyl ester (KEE), Dex-Ketoprofen, Loxoprofen Acid, Ketoprofen, Silodosin, Omeprazole, L-Arginine, Piroctone olamine, Ticagrelor, and other specialized compounds. The company targets pharmaceutical manufacturers, nutraceutical producers, and personal care and veterinary product developers as its primary customers, serving the broader healthcare and wellness industry segments. The business model focuses on supplying high-quality chemical compounds used in the formulation of medicines and health-related products. Anlon Healthcare Ltd. leverages its expertise in chemical synthesis to deliver tailored solutions for clients in the pharmaceutical sector, ensuring compliance with industry standards. Its product range supports diverse applications, from human medicine to veterinary care and personal care products, enabling it to serve multiple market segments with a single production infrastructure. Revenue streams are derived from direct sales of its chemical products to manufacturers across pharmaceutical, nutraceutical, personal care, and veterinary industries. The company's offerings are designed to meet the specific needs of these sectors, with products like Omeprazole for gastrointestinal treatments and Ticagrelor for cardiovascular care. By providing essential raw materials, Anlon Healthcare Ltd. positions itself as a critical supplier within the healthcare supply chain. Anlon Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Anlon Healthcare stock

EBIT Margin (Operating Margin) of Anlon Healthcare is 26.91 % in 2026.

EBIT Margin (Operating Margin) of Anlon Healthcare changed from 25.41 % to 26.91 %, representing a 5.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Anlon Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Anlon Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Anlon Healthcare

All Key Metrics — Anlon Healthcare